Chatbot Implementation In The Clinical Informed Consent Process
ConditionInformed Consent
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center
About this trial
The purpose of this study is to determine the feasibility of implementing the chatbot "CoCo" in the IC process for research studies. We hypothesize that implementing a chatbot into the IC process will facilitate accurate information delivery and enhance participant comprehension and process satisfaction compared to traditional remote consent methods.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Ability to understand and willingness to provide informed consent.
Age ≥18 years.
Patients whose preferred language is English.
Patients who are being considered for enrollment in selected clinical research studies.
Disqualifiers
None
Trial design
Design model
Single group
Treatments tested in this trial
CoCo Chatbot
Other interventionA patient-facing chatbot designed to obtain informed consent
Treatment groups
100 Participants
are divided into 1 treatment groupGroup A: Phase I Feasibility Cohort: Remote IC Process for Non-Therapeutic StudiesExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Safety and Adverse Events (AEs)
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Time frame
Through study completion; an average of 1 yearSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: